[#DIV28SUPER] Watch it LIVE! 2019 Annual Vermont Center on Behavior & Health National Conference

PLEASE FORWARD BELOW:

7th Vermont Center on Behavior and Health Annual Conference

COMPLEMENTARY CONTRIBUTIONS OF TOBACCO CONTROL & REGULATORY SCIENCE RESEARCH TO PROTECTING THE PUBLIC HEALTH

October 10-11, 2019

Burlington Hilton Hotel, Burlington, Vermont

The 7th Annual VCBH Conference will focus on the intersection between tobacco regulatory science and tobacco control, two of the major fields in tobacco research. We will bring together renowned researchers in both fields to see how each may compliment one another to decrease tobacco use nationwide.

 

This year's keynote speaker is Dorothy Hatsukami, Ph.D., Forster Family Chair in Cancer Prevention at the Masonic Cancer Center and Professor of Psychiatry at the University of Minnesota. Dr. Hatsukami's areas of expertise include nicotine addiction and its treatment, including testing medications such as nicotine vaccine and combination medications, in smokers.

Unable to attend? Watch the conference LIVE at: https://livestream.com/VCBH/Conference2019 

For more information and to view our program, please visit our conference webpage.

[#DIV28SUPER] NIDA Neuroscience Update, Oct 4, 2019

Table of contents

 

I.                    The 2019 NIDA-NIAAA Frontiers in Addiction Research Mini-Convention, October 18, 2019, at the annual meeting of the Society for Neuroscience [SfN].

II.                  NIH Funding and You: Early Career and Early Career Investigator Symposium at SFN.

III.                NIDA Funding Opportunity Announcements

IV.               Call for Abstract Submissions for NIDA Genetics and Epigenetics Meeting, January 13-14, 2020 at NIDA HQ due October 18, 2019

--

 

I.                    The 2019 NIDA-NIAAA Frontiers in Addiction Research Mini-Convention, October 18, 2019, at the annual meeting of the Society for Neuroscience [SfN].

 

The annual NIDA-NIAAA Mini-Convention provides a forum for presentations and discussions of current topics in neuroscience and addiction research. Additionally, the Mini-Convention showcases research by premier early stage and junior investigators and is highlighted by a keynote address from the Jacob P. Waletzky Memorial Award Recipient. This year’s scientific sessions are: 1) Sensing New Opportunities for Addiction Neuroscience; 2) Novel Technologies and Innovative Approaches for Translational Research Targeting Alcohol and Substance Use Disorders; and 3) Rewriting Genes by CRISPR for Substance Dependence and Psychiatric Disorder Research. For additional information, please contact Roger Sorensen, NIDA [ rsorense@mail.nih.gov ] or John Matochik, NIAAA [ jmatochi@mail.nih.gov ], or visit https://apps1.seiservices.com/nida-niaaa/frontiers2019/.

 

 

II.            NIH Funding and You: Early Career and Early Career Investigator Symposium at SFN.

 

Date and Time: October 21, 2019 at 6:30-9:00 pm

Location: McCormick Place Convention Center, Room S104

Food: Please visit before attending: Marriott Marquis Chicago, Hyatt Regency McCormick Place, or Hiltons at McCormick Place

 

There will be presentations from Program and Review staff from the National Institute on Drug Abuse (NIDA, NIH) on fellowships (F30, F31, F32, F99/K00), institutional appointments (T32, R25, K12), transition awards (K99/R00), mentored career development awards (K01, K08, K23, K25), special opportunities for international students, postdoctoral opportunities in NIH laboratories, independent research grants (R01, DP2, R03, and R21), and insights from review. Presentations will be followed by the opportunity to meet with Dr. Apkar Vania Apkarian, T32 directors, and NIDA staff.

A special headliner this year will be Dr. Apkarian, Project Director of the Center for Chronic Pain and Drug Abuse (P50) who will speak on pain, addiction, and P50 workforce opportunities. In keeping with the need to educate attendees about institutional appointments, T32 Project Directors will meet with students during our discussion period.

 

III.          NIDA Funding Opportunity Announcements

 

RFA-DA-20-010  The Rat Opioid Genome Project: Clinical Trials not Allowed (U01- Clinical Trial Not Allowed) https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-20-010.html

Application due date:  November 19, 2019, by 5:00 PM local time of applicant organization

 

RFA-DA-20-027  Single Cell Opioid Responses in the Context of HIV (SCORCH) Program: Data Coordination, Analysis, and Scientific Outreach (UM1 Clinical Trial Not Allowed)

https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-20-027.html

Application due date: January 15, 2020, by 5:00 PM local time of applicant organization

PAR-19-278  Exploiting Genome or Epigenome Editing to Functionally Validate Genes or Variants Involved in Substance Use Disorders (R21/R33 Clinical Trial Not Allowed)

https://grants.nih.gov/grants/guide/pa-files/PAR-19-278.html

Next Application due dates: December 18, 2019, and June 24, 2020 by 5:00 PM local time of applicant organization

 

PAR-18-742  Exploring Epigenomic or Non-Coding RNA Regulation in the Development, Maintenance, or Treatment of Chronic Pain (R61/R33 Clinical Trial Optional)

https://grants.nih.gov/grants/guide/pa-files/par-18-742.html

Next Application due date:  November 13, 2019 and February 11, 2020,  by 5:00 PM local time of applicant organization

PAR-17-242  Extracellular Vesicles and Substance Use Disorders (R21)

https://grants.nih.gov/grants/guide/pa-files/par-17-242.html

Next Application due dates: November 3, 2019 and March 3, 2020 by 5:00 PM local time of applicant organization

 

PAR-17-250 Extracellular Vesicles and Substance Use Disorders (R01)

https://grants.nih.gov/grants/guide/pa-files/PAR-17-250.html

Application due dates: November 3, 2019 and March 3, 2020, by 5:00 PM local time of applicant organization

--

 

IV.          Call for Abstract Submissions for NIDA Genetics and Epigenetics Meeting, January 13-14, 2020 at NIDA HQ

The Genetics and Epigenetics Cross Cutting Research Team of the National Institute on Drug Abuse invites you to submit an abstract for the January 13-14, 2020 NIDA Genetics Consortium Meeting at NIDA headquarters, 6001 Executive Blvd, Rockville, MD 20850. Abstract submission opens September 9, 2019 and closes October 18, 2019. We will open registration in early October. Agenda to be posted soon.

Please submit your abstract to NGCAbstracts@nida.nih.gov as a PDF with the following format. PDFs not conforming to this format will be returned.  

Submitter Name:                                                                    

Submitted email:

PI Name (if different):                                                            

PI email (if different):

 

Clever title for your abstract

 

First Name Last Name¹, First Name Last Name^1,2, First Name Last Name³, and First Name Last Name^1,4

¹Department, University; ²Department, University; ³Department, University; ⁴Department, University

 

The Abstract should discuss the background, rationale/significance, hypothesis, results and discussion. The font size should be Arial 11 pt. The body of the abstract should be 250 words, maximum and fully justified. Please submit the abstract as a PDF document. Abstracts are due by Midnight PST on October 18, 2019. Abstracts not conforming to this format or sent to another email will not be accepted for review and may be returned to the sender. Abstracts sent to another email will not be returned.

See examples at:  (NIDA Genetics Consortium Meeting Abstracts). 

The goals of the meeting are to:

• Showcase the exciting research on the genetics and epigenetics of substance use disorders
• Encourage collaboration among investigators with different expertise in genetics and epigenetics
• Foster collaboration between investigators working on the genetics and epigenetics of substance abuse disorders and HIV/AIDS investigators
• Identify new research opportunities in the genetics and epigenetics of substance use disorders 
• Provide attendees with an opportunity to meet with NIDA program directors to discuss their ideas for grant applications and funding opportunities 

 

The NIDA Genetics and Epigenetics Cross-Cutting Research Team will select up to 12 abstracts for short talks and up to 160 abstracts for poster presentations. We may invite some investigators to serve as panel discussants. Abstracts should focus on the genetics and epigenetics of substance use disorders in humans or in model systems. We encourage submissions across all career stages (e.g. graduate students, postdoctoral scientists, junior and senior faculty). Abstracts are due by Midnight PST on Oct 18, 2019. Decisions on acceptance of poster presentations and short talks will be made on a rolling basis, and no later than November 15, 2019.

 

There is no registration fee to attend this meeting, however attendees are responsible for their own travel, meals, and lodging.

Jonathan D. Pollock, Ph.D.

Chief

Genetics, Epigenetics, and Developmental Neuroscience Branch

Division of Neuroscience and Behavior

National Institute on Drug Abuse, NIH

6001 Executive Blvd, Rm. 4267

Bethesda, MD 20892

Tel. 301-435-1309

Email. jpollock@mail.nih.gov

Skype: Dogmacentral1

 

The National Institute on Drug Abuse at the National Institutes of Health is an agency of the United States Department of Health and Human Services  TO UNSUBSCRIBE: send email to listserv@list.nih.gov Copy and paste UNSUBSCRIBE NIDA_NEURO_SCIENCE-L   in the message body of the email - You will receive a confirmation email if successful. If you have problems contact jpollock@mail.nih.gov   301-435-1309

 

 

[#DIV28SUPER] Interprofessional Advanced Fellowship in Addiction Treatment VA San Diego Healthcare System

Interprofessional Advanced Fellowship in Addiction Treatment VA San Diego Healthcare System (VASDHS)

The VA San Diego Healthcare System (VASDHS) is one of seven sites selected for a VA-funded Interprofessional Advanced Fellowship in Addiction Treatment. Our two-year advanced fellowship is recruiting clinical/counseling psychologists and physicians. Advanced Fellows must demonstrate an interest in pursuing VA and/or academic careers with addiction treatment as a significant focus. Fellows will spend at least 75% of their time in educational experiences and clinical research in addiction treatment. No more than 25% of fellow effort shall be for non-educational clinical service. Research mentors hold appointments at VASDHS and/or the University of California, San Diego (UC San Diego). These include Drs. Tamara Wall and Scott Matthews (Co-Directors), Abigail Angkaw, Robert Anthenelli, Sandra Brown, Neal Doran, Eric Granholm, Igor Grant, Moira Haller, Joanna Jacobus, Mallory Loflin, Nick Mellos, Mark Myers, Sonya Norman, Marc Schuckit, Andrea Spadoni, Susan Tapert, Ryan Trim, and Matthew Worley. Faculty research interests include comorbidity and treatment outcome research, tobacco-related research, brain imaging and neuropsychological sequelae, etiology and genetics of substance use disorders. Please see the UC San Diego, Department of Psychiatry website for research interests of individual faculty mentors as well as additional information about our affiliate.

Application: Please submit a letter of interest (maximum 2 pages), CV, and 3 letters of recommendation. The letter of interest should include: a brief summary of educational, clinical and research experiences relevant to addictions and a statement of career goals, including research mentor(s) with whom you might be interested in working. For psychologist applicants, materials should be submitted via the Association of Psychology Postdoctoral and Internship Centers (APPIC) Psychology Postdoctoral Application (APPA CAS) website: https://appicpostdoc.liaisoncas.com/. For physician applicants, materials should be submitted by email to vafellowship@ucsd.edu. The application deadline for psychologist positions is December 1, 2019 at 11:59 pm. Late applications will be considered only for positions that are not filled by applicants who applied by December 1st. Applicants should be available for an interview in early 2020. Phone interviews are possible. Please contact Dr. Tamara Wall (Tamara.Wall@va.gov) with questions about the psychologist position or Dr. Scott Matthews (Scott.Matthews@va.gov) with questions about the physician position.


_____________________ div28SUPER@lists.apa.org _____________________
Div28m members #div28 subscribers corner: http://lists.apa.org

[#DIV28SUPER] CASAA Director Search

Dear Friends and Colleagues,

A reminder that the University of New Mexico has launched a search for a Director for the Center on Alcoholism, Substance Abuse and Addictions (CASAA). This is a tenured faculty position with full academic year salary support. I wanted to let everyone on the listserv know about the search and would welcome suggestions for the position. Please also forward this email to others you know who might have an interest. I have attached the full position announcement to this email.

Established in 1989, CASAA has developed an outstanding international reputation as a center for research on the epidemiology, prevention and treatment of alcohol and drug use disorders and the adverse consequences of use. CASAA's 80 staff, faculty, and affiliated members have the mission of generating, conveying, and applying knowledge to reduce the suffering related to addiction. 

Please let me know if you have suggestions for candidates or if you would like additional information about the position. You also can submit a nomination or application for the position at http://casaadirectorsearch.unm.edu.  This website also includes additional details about the position including the position summary, and the minimum and preferred qualifications.

The best consideration date for applications is October 15, 2019

With Warm Regards,

Barbara

Barbara S. McCrady, Ph.D.

Distinguished Professor, Psychology and

Center on Alcoholism, Substance Abuse and Addictions (CASAA)

Chair, CASAA Director Search Committee

2650 Yale Blvd. SE

Albuquerque, NM 87106

CASAA phone: 505-925-2388

Psychology phone: 505-277-8857

bmccrady@unm.edu

 

 

 

[#DIV28SUPER] Opening for a Behavioral Science PhD student at the University of North Texas (Addictive Behaviors focus)

Dear Colleagues,

I am requesting that you share this announcement about applying to the University of North Texas (UNT) Behavioral Science PhD Program, which is part of the UNT Department of Psychology in Denton, located in the greater Dallas-Fort Worth area.

In particular, I (Dr. Casey Guillot) am looking to accept an applicant as a doctoral student to start in the Fall 2020 semester. This student will be mentored by me and will work as a research assistant in my lab, the Disposition, Emotion, & Addiction Research (DEAR) Laboratory, which is broadly interested in the etiology of addictive behaviors. The DEAR Lab recently initiated an experimental study on anxiety sensitivity and other psychological factors (e.g., experiential avoidance, executive functioning) in relation to the effects of cigarette smoking, and will soon initiate a survey study on potential associations of discrimination experiences, personality, and mood with various health behaviors (e.g., social media and alcohol, cigarette, e-cigarette, cannabis, and other substance use). Behavioral Science faculty members with additional research interests will also be considering applicants, including Drs. Kim Kelly, Rex Wright, Yolanda Flores-Niemann, Adriel Boals, and Danica Slavish. For students interested in applying to work with me, I recommend visiting my lab website: DEAR Lab website

For further information on the UNT Behavioral Science PhD Program, including faculty research interests and a link to the program page, please see the attached announcement. The deadline for applying to the Behavioral Science PhD Program is December 1.

Thank you for sharing this information.

Best,

Casey Guillot, PhD

Assistant Professor of Psychology

Behavioral Science Program

University of North Texas

Office: Terrill Hall 382

Phone: 940-369-8426

Lab Website: http://psychology.unt.edu/disposition-emotion-addiction-research-dear-laboratory

[#DIV28SUPER] Apply Online: Assistant/Associate Professor, University of Florida Department of Psychiatry

Online Application Open, see link below.

 

The Department of Psychiatry at the University of Florida has initiated a search for an addiction scientist with expertise in clinical research and/or the analysis of large data to inform clinically relevant questions in addiction science. We hope you'll share this posting with qualified colleagues and senior-level postdoctoral fellows!

 

 

 

Assistant/Associate Professor Position

University of Florida, College of Medicine, Department of Psychiatry

Location: Gainesville, Florida

 

Apply Online: https://apply.interfolio.com/68960

 

Description

The Department of Psychiatry at the University of Florida is recruiting a faculty position at the Assistant or Associate Professor level with clear research expertise in clinical addiction science and specific skills in the study of a) lifespan trajectories, and/or b) psychiatric and medical comorbidities, and/or c) the application of large data sets to inform science, practice, and policy. The successful candidate must be able to work effectively with multi-disciplinary teams and diverse populations. This position provides opportunities to collaborate with diverse addiction scientists at UF through its Center for Addiction Research & Education (UF CARE). UF CARE has over 44 faculty scientists who represent 7 UF Colleges and 14 academic departments. UF is also an active site for the Adolescent Brain Cognitive Development (ABCD) Study, a landmark NIH funded study of development through adolescence. Addiction faculty in the department are engaged in UF and national collaborations that afford rich opportunities for career development. As a faculty member in the College of Medicine, the candidate will be expected to not only participate in both independent and collaborative research programs, but to also contribute to its education mission by participating in graduate and/or medical education. Finally, the successful candidate must be willing to engage in service at the level of the department, college, and larger profession. We are seeking a self-driven, emerging, or established researcher with exceptional potential as a leader in their field.

 

Qualifications

Eligible applicants require a Ph.D., or equivalent degree, with postdoctoral experience including work in clinical addiction science whether in psychology (cognitive, developmental, clinical), neuroscience, or a related field. Documented evidence of productivity based on publications in appropriate peer-reviewed journals and scientific presentations are requisite. Successful competition for and/or evidence of a high probability for conduct of an externally funded program of research is also required. Evidence for mentoring students and productive and collegial interactions with scientific and clinical colleagues will also be important considerations. Minimum requirements include a doctorate in a relevant discipline, and 3-5 years of post-doctoral experience.

 

Application Instructions

Please email three letters of recommendation to Dr. Sara Jo Nixon at sjnixon@UFL.EDU upload a CV, cover letter, and transcripts to complete your online application. This position is open until filled. Application review will begin immediately and continue until the position is filled.

 

Selected candidate will be required to provide an official transcript to the hiring department upon hire. A transcript will not be considered "official" if a designation of "Issued to Student" is visible. Degrees earned from an educational institution outside of the United States are required to be evaluated by a professional credentialing service provider approved by National Association of Credential Evaluation Service (NACES).

 

If an accommodation due to a disability is needed to apply for this position, please call 352-392-2477 or the Florida Relay System at 800-955-8771 (TDD). Hiring is contingent upon eligibility to work in the US. Searches are conducted in accordance with Florida's Sunshine Law.

 

Equal Employment Opportunity Statement

The University of Florida is committed to non-discrimination with respect to race, creed, color, religion, age, disability, sex, sexual orientation, gender identity and expression, marital status, national origin, political opinions or affiliations, genetic information and veteran status in all aspects of employment including recruitment, hiring, promotions, transfers, discipline, terminations, wage and salary administration, benefits, and training.

 

SJN

 

Sara Jo Nixon, Ph.D.

Director, Center for Addiction Research and Education

University of Florida Research Foundation Professor 2015-2017

Professor Departments of Psychiatry and Psychology

Co-Vice Chair, Department of Psychiatry

Co-Director, NIDA T32

Chief, Division of Addiction Research

Director, Neurocognitive laboratory

University of Florida

[#DIV28SUPER] Tenure-track Assistant Professor in Clinical Health Psychology

Dear colleagues and friends,

 

We are hiring at the University of New Mexico! Please come join us in Psychology with excellent opportunities for collaboration at the Center on Alcoholism, Substance Abuse, and Addictions, the NM Alcohol Research Center, the Department of Psychiatry and Behavioral Sciences, the Mind Research Network, and the newly funded Southwest Clinical Trials Network Node and Substance Use Research and Education Center (SURE).

 

See ad for more information below and I apologize for cross-postings.

 

Katie Witkiewitz, PhD

Regents’ Professor

Department of Psychology

Center on Alcoholism, Substance Abuse, and Addictions

University of New Mexico

 

 

The Department of Psychology at The University of New Mexico (UNM) invites applications for a Clinical Health Psychology position at the Assistant Professor level for a full-time, tenure-track appointment targeted to begin August 1, 2020.  Candidates must have completed a doctoral degree in Clinical or Counseling Psychology from an APA/CPA/PCSAS accredited program at the time of appointment.  In addition, an APA/CPA approved clinical psychology internship and evidence of research and peer-reviewed publications in clinical health psychology are considered minimum qualifications for this position.

 

We seek a highly committed Clinical Health Psychologist who is determined to contribute to the research and teaching missions in the areas of Clinical and Health Psychology.  The specific research area within Clinical Health Psychology is open, but broad examples include: stress and coping with chronic illness and pain, prevention and health behavior change, health psychology interventions, adherence, and psychosocial pathways to health and illness. Successful candidates for this position will be expected to teach and mentor at the undergraduate and graduate levels, including graduate level courses in clinical health psychology. The UNM Department of Psychology, which includes 26 tenure-track faculty and 76 Ph.D. students, has internationally recognized research programs. External research grants exceeded $8 million in funding last year. The successful candidate will have numerous opportunities for collaboration within the department and in thriving cross-disciplinary research centers affiliated with UNM, including the UNM Health Sciences Center; Transdisciplinary Research, Equity, and Engagement (TREE) Center for Excellence in Health Disparities;  Center for Social Policy (focused on health disparities research and health policy); the Mind Research Network (a nationally recognized neuroimaging center); the Center on Alcoholism, Substance Abuse, and Addictions (CASAA); and the New Mexico Veteran’s Administration Health Care System.  There are also opportunities for studying a full range of health problems such as heart disease, cancer, chronic pain, obesity, addiction, and diabetes; with diverse populations including racial and ethnic minorities and people with low income; and in a variety of settings  including telehealth systems to reach distant and underserved populations. The UNM Main and Health Sciences campuses are adjacent to one another, facilitating interdisciplinary collaboration.

 

Preferred qualifications include: 1) evidence of teaching experience broadly defined as teaching undergraduate or graduate courses, workshops, trainings, supervision/mentoring, or teaching assistantships, 2) research experience, as evidenced by publications and ongoing research centrally located in clinical  health psychology, 3) demonstrated potential for research funding,  4) demonstrated commitment to diversity, equity, inclusion, and student success, including working with broadly diverse communities, and 5) pre and postdoctoral training that demonstrates a breadth of experiences in the provision and supervision of clinical assessment and intervention.

 

UNM is the state’s flagship University and is one of only four Hispanic-serving, Carnegie Research/Doctoral-Extensive institutions in the US.  UNM is located in the high desert locale of Albuquerque, NM, the largest urban area in one of the most diverse states in the nation. For more information on the benefits of living and working in Albuquerque, NM, see https://advance.unm.edu/why-abq/ and https://www.newmexico.org/.

 

Applicants should submit cover letter, CV, description of current and planned research, teaching portfolio, and diversity statement via the UNMJOBS website, ReqID#10574.  Three letters of recommendation must be sent directly to the department (MSC03-2220, Dept. Psychology, University of New Mexico, Albuquerque, NM 87131) or via email to psychjobs@unm.edu by the for best consideration date.

 

Consideration of applications will begin immediately. For full consideration apply by November 15, 2019. The position will remain open until filled.  Inquiries can be directed to Sarah Erickson, Ph.D., Chair, Faculty Search Committee, erickson@unm.edu.  The University of New Mexico is an Equal Opportunity/Affirmative Action employer and educator; women and minorities are strongly encouraged to apply.